These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
458 related articles for article (PubMed ID: 2547840)
1. Autonomous growth of a human neuroblastoma cell line is mediated by insulin-like growth factor II. El-Badry OM; Romanus JA; Helman LJ; Cooper MJ; Rechler MM; Israel MA J Clin Invest; 1989 Sep; 84(3):829-39. PubMed ID: 2547840 [TBL] [Abstract][Full Text] [Related]
2. Insulin-like growth factor receptor expression and function in human breast cancer. Cullen KJ; Yee D; Sly WS; Perdue J; Hampton B; Lippman ME; Rosen N Cancer Res; 1990 Jan; 50(1):48-53. PubMed ID: 2152773 [TBL] [Abstract][Full Text] [Related]
3. Insulin-like growth factor II-mediated proliferation of human neuroblastoma. El-Badry OM; Helman LJ; Chatten J; Steinberg SM; Evans AE; Israel MA J Clin Invest; 1991 Feb; 87(2):648-57. PubMed ID: 1991849 [TBL] [Abstract][Full Text] [Related]
4. Autocrine function for insulin-like growth factor I in human small cell lung cancer cell lines and fresh tumor cells. Macaulay VM; Everard MJ; Teale JD; Trott PA; Van Wyk JJ; Smith IE; Millar JL Cancer Res; 1990 Apr; 50(8):2511-7. PubMed ID: 2156621 [TBL] [Abstract][Full Text] [Related]
5. Insulin-like growth factor-II expression in carcinoma in colon cell lines: implications for autocrine actions. Guo YS; Jin GF; Townsend CM; Zhang T; Sheng HM; Beauchamp RD; Thompson JC J Am Coll Surg; 1995 Aug; 181(2):145-54. PubMed ID: 7627387 [TBL] [Abstract][Full Text] [Related]
6. Insulin-like growth factor-I can mediate autocrine proliferation of human small cell lung cancer cell lines in vitro. Nakanishi Y; Mulshine JL; Kasprzyk PG; Natale RB; Maneckjee R; Avis I; Treston AM; Gazdar AF; Minna JD; Cuttitta F J Clin Invest; 1988 Jul; 82(1):354-9. PubMed ID: 2839551 [TBL] [Abstract][Full Text] [Related]
7. Suramin inhibits the growth of human rhabdomyosarcoma by interrupting the insulin-like growth factor II autocrine growth loop. Minniti CP; Maggi M; Helman LJ Cancer Res; 1992 Apr; 52(7):1830-5. PubMed ID: 1312901 [TBL] [Abstract][Full Text] [Related]
8. Role of growth factor synthesis in the acquisition of insulin/insulin-like growth factor I independence in rat mammary carcinoma cells. Ethier SP; Chiodino C; Jones RF Cancer Res; 1990 Sep; 50(17):5351-7. PubMed ID: 1696849 [TBL] [Abstract][Full Text] [Related]
9. Evidence for autocrine mitogenic stimulation by somatomedin-C/insulin-like growth factor I on an established human lung cancer cell line. Minuto F; Del Monte P; Barreca A; Alama A; Cariola G; Giordano G Cancer Res; 1988 Jul; 48(13):3716-9. PubMed ID: 3378214 [TBL] [Abstract][Full Text] [Related]
10. Interferon-gamma inhibits DNA synthesis and insulin-like growth factor-II expression in human neuroblastoma cells. Martin DM; Carlson RO; Feldman EL J Neurosci Res; 1993 Apr; 34(5):489-501. PubMed ID: 8478984 [TBL] [Abstract][Full Text] [Related]
11. N-myc regulation of type I insulin-like growth factor receptor in a human neuroblastoma cell line. Chambéry D; Mohseni-Zadeh S; de Gallé B; Babajko S Cancer Res; 1999 Jun; 59(12):2898-902. PubMed ID: 10383152 [TBL] [Abstract][Full Text] [Related]
12. Insulin-like growth factor-II expression is down-regulated in TrkA-transfected SK-N-AS neuroblastoma cells. Kim CJ; Chi JG; Thiele CJ Lab Invest; 1999 Aug; 79(8):1007-13. PubMed ID: 10462038 [TBL] [Abstract][Full Text] [Related]
13. Insulin-like growth factor II acts as an autocrine growth and motility factor in human rhabdomyosarcoma tumors. El-Badry OM; Minniti C; Kohn EC; Houghton PJ; Daughaday WH; Helman LJ Cell Growth Differ; 1990 Jul; 1(7):325-31. PubMed ID: 2177632 [TBL] [Abstract][Full Text] [Related]
14. Expression of insulin-like growth factor-binding protein 6 complementary DNA alters neuroblastoma cell growth. Grellier P; De Galle B; Babajko S Cancer Res; 1998 Apr; 58(8):1670-6. PubMed ID: 9563481 [TBL] [Abstract][Full Text] [Related]
15. Insulin-like growth factor I and transforming growth factor alpha as autocrine growth factors in human pancreatic cancer cell growth. Ohmura E; Okada M; Onoda N; Kamiya Y; Murakami H; Tsushima T; Shizume K Cancer Res; 1990 Jan; 50(1):103-7. PubMed ID: 2152769 [TBL] [Abstract][Full Text] [Related]
16. Regulation of insulin-like growth factor-IL expression and its role in autocrine growth of human neuroblastoma cells. Martin DM; Feldman EL J Cell Physiol; 1993 May; 155(2):290-300. PubMed ID: 8482722 [TBL] [Abstract][Full Text] [Related]
17. Growth inhibition of human breast cancer cells in vitro with an antibody against the type I somatomedin receptor. Arteaga CL; Osborne CK Cancer Res; 1989 Nov; 49(22):6237-41. PubMed ID: 2553250 [TBL] [Abstract][Full Text] [Related]
18. Soluble insulin-like growth factor II/mannose 6-phosphate receptor inhibits DNA synthesis in insulin-like growth factor II sensitive cells. Scott CD; Weiss J J Cell Physiol; 2000 Jan; 182(1):62-8. PubMed ID: 10567917 [TBL] [Abstract][Full Text] [Related]
19. Human osteosarcoma (U-2 OS) cells express both insulin-like growth factor-I (IGF-I) receptors and insulin-like growth factor-II/mannose-6-phosphate (IGF-II/M6P) receptors and synthesize IGF-II: autocrine growth stimulation by IGF-II via the IGF-I receptor. Raile K; Höflich A; Kessler U; Yang Y; Pfuender M; Blum WF; Kolb H; Schwarz HP; Kiess W J Cell Physiol; 1994 Jun; 159(3):531-41. PubMed ID: 8188767 [TBL] [Abstract][Full Text] [Related]
20. Inhibition of proliferation in human MNNG/HOS osteosarcoma and SK-ES-1 Ewing sarcoma cell lines in vitro and in vivo by antagonists of growth hormone-releasing hormone: effects on insulin-like growth factor II. Braczkowski R; Schally AV; Plonowski A; Varga JL; Groot K; Krupa M; Armatis P Cancer; 2002 Oct; 95(8):1735-45. PubMed ID: 12365022 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]